ALESSANDRO LAGANÀ

Dottorando

ciclo: XL
email:





Produzione scientifica

11573/1702043 - 2024 - Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation
Lagana, Alessandro; Passucci, Mauro; Pepe, Sara; Scalzulli, Emilia; Carmosino, Ida; Costa, Alessandro; Bisegna, Maria Laura; Ielo, Claudia; Martelli, Maurizio; Breccia, Massimo - 01a Articolo in rivista
rivista: EUROPEAN JOURNAL OF HAEMATOLOGY (Blackwell Munksgaard:PO Box 2148, Periodicals Department, DK-1016 Copenhagen K Denmark:011 45 33 755913, EMAIL: agentservices@oxon.blackwellpublishing.com, INTERNET: http://www.blackwellmunksgaard.com, Fax: 011 45 77 333377) pp. - - issn: 0902-4441 - wos: WOS:001159783600001 (2) - scopus: 2-s2.0-85184861453 (2)

11573/1721596 - 2024 - Treatment free remission (TFR) after second-generation tyrosine kinase inhibitors (2G-TKIs) treatment in chronic myeloid leukemia (CML): from feasibility to safety
Lagana, Alessandro; Scalzulli, Emilia; Bisegna, Maria Laura; Carmosino, Ida; Ielo, Claudia; Costa, Alessandro; Torrieri, Lorenzo; Totaro, Matteo; Martelli, Maurizio; Breccia, Massimo - 01g Articolo di rassegna (Review)
rivista: EXPERT OPINION ON DRUG SAFETY (-London United Kingdom:Informa Healthcare -London Ashley Publications) pp. 969-979 - issn: 1474-0338 - wos: (0) - scopus: (0)

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma